Clinical Trial Update: Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vaginal progesterone to prevent preterm delivery in women with preterm labor was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Vaginal progesterone (progesterone)

Snippet

Sponsor: begoña Martinez de Tejada | Conditions: Preterm Delivery, Morbidity | Phase 3 | Status: TERMINATED